Healio: Team-based telehealth model as effective as in-person care for eczema

A new clinical trial published in JAMA Dermatology adds to the growing body of evidence that virtual dermatology can deliver high-quality outcomes for patients with chronic skin conditions. The study, which was funded by the NIH, found that a coordinated, asynchronous telehealth model achieved outcomes comparable to in-person care for patients with atopic dermatitis (eczema), highlighting the opportunity to expand access while ensuring patients receive the right level of care for their needs.

Beyond demonstrating the effectiveness of virtual care, the findings raise an important question for the future of dermatology: how can healthcare systems build sustainable care models that improve access, optimize specialist capacity, and align incentives with patient outcomes?

Dr. Rachel Day, Zest Health’s Chief Medical Officer, was asked by Healio, a news outlet for physicians and healthcare professionals, to share her perspective on the study and why technology-enabled dermatology models can help support more personalized, outcomes-driven care.

Read the full article for more on the study and Dr. Day’s perspective on the future of value-based dermatology care: